Growth Metrics

Amphastar Pharmaceuticals (AMPH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $7422.0.

  • Amphastar Pharmaceuticals' Other Working Capital Changes fell 9993.08% to $7422.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7422.0, marking a year-over-year decrease of 9994.43%. This contributed to the annual value of $10.7 million for FY2024, which is 197522228.36% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Other Working Capital Changes of $7422.0 as of Q3 2025, which was down 9993.08% from $66.0 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Other Working Capital Changes high stood at $10.7 million for Q3 2024, and its period low was -$1.8 million during Q4 2021.
  • Its 5-year average for Other Working Capital Changes is $711473.5, with a median of $5614.0 in 2022.
  • Data for Amphastar Pharmaceuticals' Other Working Capital Changes shows a peak YoY increase of 197595893.19% (in 2024) and a maximum YoY decrease of 8670000.0% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Other Working Capital Changes stood at -$1.8 million in 2021, then skyrocketed by 282.32% to $3.2 million in 2022, then fell by 11.36% to $2.8 million in 2023, then crashed by 91.63% to $237000.0 in 2024, then tumbled by 96.87% to $7422.0 in 2025.
  • Its Other Working Capital Changes was $7422.0 in Q3 2025, compared to $66.0 in Q2 2025 and $66.0 in Q1 2025.